{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.46G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "46"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "c.46G>A (p.E46K)"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.53T>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "L",
            "position": "53"
          },
          "Description in input context": "c.53T>A (p.A53T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0100247"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro polymerization assays and structural analysis of amyloid fibrils",
      "Material used": {
        "Material Source": "In vitro protein expression system",
        "Material Name": "Recombinant α-synuclein",
        "Description": "Protein was expressed and purified from E. coli."
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.46G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K mutation promotes amyloid fibril formation compared to wild-type α-synuclein."
        },
        {
          "Variant": "NM_001126112.3:c.53T>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mutation also promotes amyloid fibril formation, but to a lesser extent than E46K."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Amyloid fibril formation not observed under standard conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Amyloid fibril formation observed with increased kinetics compared to wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}